Neurotechnology Ventures

[Class Content]   [Fall 2014]  [Fall 2013]  [Fall 2012]  [Fall 2011]  [Fall 2010]  [Fall 2009]  [Spring 2007]  

MIT Course Numbers: 9.455 ~ 15.128 ~ 20.454 ~ HST.588 ~ MAS.883
Instructors: J. Bonsen ~ E.S. Boyden ~ R.G. Ellis-Behnke
Units: H-level ~ 2-0-7 Units
Time: Tuesdays, 8-10pm (7-9pm after Nov. 3rd, when daylight savings ends); Begins Sept. 9, 2008
Place: Room 46-3189
Special note: Class sessions will be live link to University of Hong Kong


Neurotechnology Ventures is a seminar and project-oriented course on the challenges of envisioning, planning, and building startups to bring neuroengineering innovations to the world. Each 2-hour class begins with a survey of a broad topic area, and continues with a live-case study of a current, specific, development or commercialization effort in that area. Explorations will cover a broad array of issues ranging from the deeply technical, to the analysis of market realities. Topics Include: Neuroimaging, Neurology/Psychiatry Diagnosis, Rehabilitation, Neurosurgery, Neuropharmacology, Brain Stimulation, Prosthetics, Sensory and Motor Augmentation, Regenerative Neuromedicine, and more.

Limited Enrollment - Email two paragraphs summarizing your: (1) Professional Skills & Experience, and (2) Inventive/Entrepreneurial Aspirations, on or before first class day.

Student Project - Students will work in teams to analyze an opportunity and create a business plan executive summary to solve a major problem through neurotechnology. The project will develop throughout the term, with multiple reviews, and culminating in a final presentation. We expect that some projects may go on to become successful ventures.


Tues., Sept. 9 Lecturers: Overview of class, introductions.

Zack Lynch, Director of the Neurotechnology Industry Organization
The Global Neurotechnology Industry 2008

Afterwards: Social event and networking.

Tues., Sept. 16 Dr. Christopher deCharms, Omneuron
Neurotechnology Applications: Real-Time Functional Brain Imaging.

Lecturers: Opportunity and needs assessment.
Lecturers: Sample 1-minute pitches by instructors.

Afterwards: Social event and networking.

Thurs., Sept. 18 Lecturers: Office hours - ideas, strategy, and pitches. Front room of Muddy Charles Pub.

Tues., Sept. 23 Dr. Dan DiLorenzo, Founder, NeuroVista.
Launching a new neurotherapeutic venture to treat epilepsy: A war story

Students: Practice 1-minute pitches. Team building, drilling down.

Afterwards: Social event and networking.

Tues., Sept. 30 Students: Practice 1-minute pitches. Refining the model.

Philip Low, Founder, Neurovigil
A Venture to Revolutionize Sleep Disorders with Automated EEG Analysis

Afterwards: Social event and networking.

Tues., Oct. 7 Students: Practice 1-minute pitches.

Neurology and psychiatry: The biggest needs and opportunities: Special Clinician Panel"
(Drs. Andrew Cole, Carl Marci, Alvaro Pascual-Leone, Mark Boguski, and Steven Schachter)

Tues., Oct. 14 Kwok-Fai So, University of Hong Kong
Molecular Mechanism of Neuroprotection in Glaucoma and Alzheimer's disease Using an Anti-aging Herbal Medicine, Gouqizi (Wolfberry)

Tues., Oct. 21 Ed Boyden, "Principles of Crafting New Ventures" and "Human, Physical, and Informational Resources for Crafting New Ventures."
Note: the midterm has been replaced by ongoing 1-on-1 coaching targeted to each team, to help each team maximally improve its work.

Tues., Oct. 28 Paul Pyzowski and Andre Mercanzini, founders of Aleva Neurotherapeutics
Flexible deep brain stimulation multiarray electrodes.

Tues., Nov. 4 Intelligent robotic prosthetics.
Dean Kamen, inventor and founder of DEKA Research.

Tues., Nov. 11 No class. Veteran's day.

Tues., Nov. 18 No class. Society for Neuroscience Meeting, Washington, DC.

Tues., Nov. 25 Spinal cord injury, stem cells, and neuroregeneration.
Prof. Wise Young, Rutgers (Director of the W M Keck Center for Collaborative Neuroscience), Spinal Cord Clinical Trial Network

Tues., Dec. 2 Final project presentations to the whole group.

Tues., Dec. 9 Final project presentations to the whole group.